Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)
China flag China · Delayed Price · Currency is CNY
43.61
-0.55 (-1.25%)
Nov 17, 2026, 3:00 PM CST

Hangzhou Alltest Biotech Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,7571,067920.381,3181,9822,179
Trading Asset Securities
319.581,3251,6571,4711,833780.2
Cash & Short-Term Investments
2,0772,3922,5782,7893,8152,960
Cash Growth
-15.54%-7.20%-7.57%-26.89%28.90%322.40%
Accounts Receivable
170.4159.05125.12100.87138.66208.2
Other Receivables
6.995.986.678.1810.3567.4
Receivables
177.4165.03131.79109.05149.02275.6
Inventory
197.48176.69160.32188.59193.66383.84
Prepaid Expenses
-1.350.7111.652.158.19
Other Current Assets
107.3296.5494.7563.2429.6341.03
Total Current Assets
2,5592,8322,9653,1614,1893,668
Property, Plant & Equipment
1,0131,018903.44759.8317.14223.62
Long-Term Investments
163.45145.05128.6722.9512.254.32
Other Intangible Assets
132.44136.82104.97110.4393.0328.12
Long-Term Deferred Tax Assets
20.0422.0522.230.1846.443.82
Long-Term Deferred Charges
21.2916.4910.3515.7217.885.66
Other Long-Term Assets
100.2972.5851.115.5318.9624.62
Total Assets
4,0094,2424,1864,1164,6954,008

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
75.72120.05104.877.61171.17360.65
Accrued Expenses
25.2931.6832.4133.1673.5144.61
Current Portion of Leases
0.980.542.3416.268.3220.06
Current Income Taxes Payable
77.4376.386.4373.9673.2661.71
Current Unearned Revenue
45.6435.0240.8441.62147.2226.27
Other Current Liabilities
16.5123.0432.3731.5637.290.91
Total Current Liabilities
241.57286.64299.19274.16510.75714.2
Long-Term Leases
5.746.871.767.6613.4417.3
Long-Term Unearned Revenue
1.322.571.642.68--
Long-Term Deferred Tax Liabilities
--0.01--3.2
Total Liabilities
248.63296.09302.6284.5524.2734.71

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
75.6579.2879.2879.2853.953.9
Additional Paid-In Capital
1,4791,6801,7081,7131,7441,733
Retained Earnings
2,2082,2022,1772,1072,4551,487
Treasury Stock
-34.59-47.41-113.01-103.4-115.56-
Comprehensive Income & Other
32.6432.1732.530.7528.390.26
Total Common Equity
3,7613,9473,8843,8274,1663,274
Minority Interest
-0.75-0.35-0.224.314.4-
Shareholders' Equity
3,7613,9463,8833,8324,1713,274
Total Liabilities & Equity
4,0094,2424,1864,1164,6954,008

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
6.727.414.123.9121.7737.36
Net Cash (Debt)
2,0702,3852,5742,7653,7932,922
Net Cash Growth
-15.53%-7.34%-6.92%-27.10%29.80%317.07%
Net Cash Per Share
26.7930.1132.5034.9147.8639.07
Filing Date Shares Outstanding
75.0677.3877.8777.5378.2479.78
Total Common Shares Outstanding
75.0678.6977.8778.1678.2479.78
Working Capital
2,3172,5452,6662,8873,6782,954
Book Value Per Share
50.1150.1649.8748.9753.2541.03
Tangible Book Value
3,6293,8103,7793,7174,0733,246
Tangible Book Value Per Share
48.3448.4248.5347.5652.0640.68
Buildings
-986.16403.78194.44198.8558.13
Machinery
-126.29117.42113.6191.6958.93
Construction In Progress
-15.34459.92488.2542.382.37